Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Men 25-35 TB-500 Protocol: Dosing Comparison

Loading Phase 2.5–5mg Twice weekly (e.g. Mon/Thu) 2–4 weeks Saturates actin-binding pathways, initiates angiogenesis at injury sites Front-loads tissue repair. Measurable symptom improvement typically appears week 2-3 Maintenance Phase 2–2.5mg Once weekly 4–8

This comparison does not assign a generated winner or score.

  • Loading Phase
  • 2.5–5mg
  • Twice weekly (e.g. Mon/Thu)
  • 2–4 weeks
  • Saturates actin-binding pathways, initiates angiogenesis at injury sites
  • Front-loads tissue repair. Measurable symptom improvement typically appears week 2-3
  • Maintenance Phase
  • 2–2.5mg
  • Once weekly
  • 4–8 weeks
  • Sustains VEGF expression, supports collagen remodelling without overstimulation
  • Maintains repair without diminishing returns. Most cost-effective phase
  • Acute Injury Protocol
  • 5mg loading → 2mg maintenance
  • Twice weekly → once weekly
  • 6–8 weeks total
  • Aligns dosing with inflammatory and proliferative phases of healing
  • Best for Grade I-II strains, post-surgical recovery, or single-event trauma
  • Chronic Overuse Protocol
  • 2.5mg loading → 2mg maintenance
  • 8–12 weeks total
  • Lower doses over longer duration reduce cost while addressing slow-healing tendinopathy
  • Appropriate for rotator cuff issues, patellar tendinosis, Achilles tendinopathy
More references

Related material